Kontrowersje wokół diagnozy mutyzmu wybiórczego – krytyczna analiza trzech przypadków w świetle współczesnych badań oraz kryteriów diagnostycznych
III Klinika Psychiatrii, Instytut Psychiatrii i Neurologii
Klinika Psychiatrii Dzieci i Młodzieży, Instytut Psychiatrii i Neurologii
Data nadesłania: 20-11-2015
Data ostatniej rewizji: 25-07-2017
Data akceptacji: 26-07-2017
Data publikacji online: 30-04-2018
Data publikacji: 30-04-2018
Autor do korespondencji
Justyna Holka-Pokorska   

Instytut Psychiatrii i Neurologii, III Klinika Psychiatrii, Sobieskiego, 9, 02-957 Warszawa, Polska
Psychiatr Pol 2018;52(2):323-343
The position of selective mutism disorder – SM – has been modified in the last edition of the classification of mental disorders DSM-5. It was removed from “Disorders of childhood and adolescence” and placed in “Anxiety disorders”. This caused two important changes in the interpretation of the symptoms of selective mutism. It highlighted anxious etiology of the disorder and also open the possibility to diagnose selective mutism in adults as a special category of anxiety disorders. The aim of this study was to present three different cases concerning the diagnostic difficulties of selective mutism (the child, the teenager and the persons who became adult during our observation) regarding current views on SM. In this study we presented the current view on the etiology, course and available therapies for selective mutism. Owing to updating the clinical knowledge about SM and describing three cases, we highlighted the controversies around the diagnosis and treatment of this disorder. Selective mutism might be a preliminary diagnosis, often leading to the diagnosis of other disorders of diverse etiology and course. Among the psychiatric aspects of the disorder, the ‘anxiety component’ of SM is crucial. In individuals with selective mutism, developmental disorders, social cognition and neurocognition deficits or dysfunctions of auditory processing often coexist. The severity and the type of comorbidities may determine the future course of the illness and the final effects of the therapy.
Journals System - logo
Scroll to top